Journal of Oncology

Clinical Study

Weekly Paclitaxel plus Capecitabine versus Docetaxel Every 3 Weeks plus Capecitabine in Metastatic Breast Cancer

Table 2

Treatment results.
Docetaxel + capecitabine (T)Paclitaxel + capecitabine (W)
Mean dose given (mg/m2) (% of planned dose)
 Docetaxel75.6 (94.6)
 Paclitaxel81.0 (101)
 Capecitabine1962.8 (98.1)1990 (99.5)
Best response
 CR 0 / 1 9 1 / 1 8
 PR 4 / 1 9 1 2 / 1 8
 SD 1 0 / 1 9 3 / 1 8
 PD 4 / 1 9 1 / 1 8
 Not evaluable for response 1 / 1 9 1 / 1 8
Main Reason for TTF
 Disease progression 9 / 1 9 8 / 1 8
 Toxicity 8 / 1 9 8 / 1 8
 Patient’s request 2 / 1 9 2 / 1 8
TTF days147174
OS days464933